|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 25/28 | |
| A61K 31/445 | |||
| A61K 31/55 |
| (11) | Number of the document | 1827468 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05771273.9 |
| Date of filing the European patent application | 2005-07-13 | |
| (97) | Date of publication of the European application | 2007-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/024656 |
| Date | 2005-07-13 |
| (87) | Number | WO 2006/071274 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 638123 P | 2004-12-23 | US |
| (72) |
GREGORY, Christopher, W., US
SMITH, Patrick, S., US
|
| (73) |
Curaxis Pharmaceutical Corporation,
1004 Chagford Way, Raleigh, NC 27614,
US
|
| (54) | Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer`s disease |
| Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer`s disease |